Two weeks into the 2025 NFL season, Minnesota Vikings QB J.J. McCarthy saw a year's worth of highs and lows. One day after the "Sunday Night Football" loss to Atlanta, Minnesota indicated that ...
Johnson & Johnson's hopes of quickly building its new cancer drug Rybrevant into a $5 billion product have been undermined by an FDA decision. The US regulator has turned down J&J's marketing ...
Johnson & Johnson has agreed to take over Intra-Cellular Therapies in a deal worth up to $14.6 billion – the second biopharma M&A announcement today. The $132-per-share agreement comes a few months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback